Selling shareholders will sell 2 million company shares through deal
By Devika Patel
Knoxville, Tenn., Sept. 22 – Neovasc Inc. said it priced a $12 million secondary sale of stock.
Selling shareholders will sell 2 million common shares at $6.00 per share, which is a 12.54% discount to the Sept. 19 closing share price of $6.86.
The shareholders are Incentive Incubator LP, Peregrine VC Investments II (Israel) LP, Peregrine VC Investments II (US Investors) LP and Peregrine VC Investments II LP.
The company will not receive any of the proceeds.
Neovasc is a Richmond, B.C.-based medical device company.
| Issuer: | Neovasc Inc.
|
| Issue: | Common stock
|
| Amount: | $12 million
|
| Shares: | 2 million
|
| Price: | $6.00
|
| Warrants: | No
|
| Pricing date: | Sept. 22
|
| Stock symbol: | Nasdaq: NVCN
|
| Stock price: | $6.86 at close Sept. 19
|
| Market capitalization: | $332.75 million
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
